Abstract:Endothelial cell seeding, a promising method to improve the performance of small-diameter vascular grafts, requires a suitable substrate, e.g. crosslinked collagen. In addition, the growth of seeded endothelial cells can be improved by local release of a heparin-binding protein, basic fibroblast growth factor (bFGF). In this study, the influence of immobilization of heparin to collagen, crosslinked using N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (EDC) in combination with N-hydroxysuccinimide (NHS), on the binding and release of bFGF was determined. Heparin was immobilized also using EDC and NHS. Furthermore, the effects of the release of bFGF from (heparinized) EDC/NHS-crosslinked collagen on the proliferation of seeded endothelial cells was studied in vitro. Immobilization of increasing amounts of heparin to EDC/NHS-crosslinked collagen (containing 14 free ϵ-amino groups per 1000 amino acid residues, E/N14C) resulted in binding of increasing amounts of bFGF to the material. Maximal bFGF binding was observed for E/N14C containing 20–30 mg heparin immobilized per gram of collagen which was obtained using a molar ratio of EDC to heparin-carboxylic acid groups of 0.4 for heparin immobilization (E/N14C-H(0.4)). Up to concentrations of 320 ng bFGF/ml, 10% of the added bFGF bound to E/N14C, while binding of bFGF to E/N14C-H(0.4) was 22%. The initial release rate of bFGF bound to E/N14C was much higher compared to bFGF bound to E/N14C-H(0.4): respectively, 30 vs. 2% in the first 6 h. After 10 days, the bFGF release from E/N14C and E/N14C-H(0.4) amounted to 83 vs. 42%, respectively. Binding of increasing amounts of bFGF resulted in increased growth of human umbilical vein endothelial cells (HUVECs) seeded on both E/N14C and E/N14C-H(0.4). Nevertheless, after 6 and 10 days of proliferation cell numbers on E/N14C-H(0.4) where higher than cell numbers on E/N14C, irrespective of the bFGF concentration used for loading of the matrix. It is concluded that heparinized, EDC/NHS-crosslinked collagen is a good synthetic vascular graft coating for in vivo endothelial cell seeding.

Crosslinking heparin to collagen scaffolds for the delivery of human platelet-derived growth factor.

Vascularization And Cellularization Of Collagen Scaffolds Incorporated With Two Different Collagen-Targeting Human Basic Fibroblast Growth Factors

Promotion of angiogenesis by sustained release of rhGM-CSF from heparinized collagen/chitosan scaffolds.

Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold

The Effect of Collagen-Targeting Platelet-Derived Growth Factor on Cellularization and Vascularization of Collagen Scaffolds

Collagen/Heparin Bi-Affinity Multilayer Modified Collagen Scaffolds for Controlled bFGF Release to Improve Angiogenesis In Vivo.

The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2.

Collagen membranes loaded with collagen-binding human PDGF-BB accelerate wound healing in a rabbit dermal ischemic ulcer model.

Highly Efficient Local Delivery of Endothelial Progenitor Cells Significantly Potentiates Angiogenesis and Full-Thickness Wound Healing.

Heparin-conjugated injectable hydrogels with sustained releasing capability for promotion of H-type vessels formation and rat femoral bone defects repair

Platelet-Derived Growth Factor Delivery Via Nanofibrous Scaffolds for Soft-Tissue Repair.

Angiogenesis is Enhanced by Sustained Delivery of rhGM-CSF from Porous Collagen-Chitosan Scaffolds

Platelet-derived Growth Factor BB Gene-Released Scaffolds: Biosynthesis and Characterization

Nanofibrous Scaffolds Incorporating Pdgf-Bb Microspheres Induce Chemokine Expression And Tissue Neogenesis In Vivo

Nano-fibrous Scaffold for Controlled Delivery of Recombinant Human PDGF-BB.

The effect of heparinized decellularized scaffolds on angiogenic capability.

Improved Endothelialization of Vascular Grafts by Local Release of Growth Factor from Heparinized Collagen Matrices

The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration.

Heparin-modified acellular dermal matrix/chitosan-doped polydopamine nanoparticles composite sponge scaffold loaded with CGF: promoting full-thickness defect wound healing

Use of Heparinized Bacterial Cellulose Based Scaffold for Improving Angiogenesis in Tissue Regeneration.

Release Kinetics and Cellular Profiles for Bfgf-Loaded Electrospun Fibers: Effect of the Conjugation Density and Molecular Weight of Heparin